Jun 1, 2026 07:28 PM
https://www.scmp.com/news/china/science/...tion-china
EXCERPTS: For decades, publishing a paper in Nature was regarded as the ultimate academic achievement in China – a fast track to promotions, research grants, hospital appointments and elite national talent programmes.
Over the past two months, Chinese social media platforms have been flooded with accusations targeting papers published in Nature and its subsidiaries, including Nature Cancer, Nature Cell Biology and Nature Nanotechnology. Several of the accused authors are prominent professors, deans, “national talent” scholars and scientists with top state honours.
[...] As of May 17, Geng claimed to have another solid piece of evidence of fabrication in research papers published in Nature or its sister journals by four scholars holding prestigious state funding. For many Chinese researchers, the anger directed at Nature is not only about potential fraud, but also about what publication in the journal represents within China’s academic system.
A Nature paper can determine whether a scientist receives millions of yuan in funding, secures tenure, qualifies for national talent schemes or earns promotions at a leading hospital. Consequently, questionable papers are increasingly viewed not merely as cases of scientific misconduct, but as evidence of unfair resource allocation in an intensely competitive system.
[...] The reputational stakes are particularly high because China has become one of Nature’s largest markets. Nature and its parent company maintain extensive commercial ties across the country through academic conferences, publishing partnerships, training programmes, data services and collaborations with Chinese universities and research institutes.
A collapse in trust would therefore threaten not only prestige but also influence and business interests. [...] But the deeper impact may already be visible. For British publication Springer Nature, the greater danger may not be a handful of retractions, but the erosion of the authority and prestige it spent more than a century building... (MORE - details)
EXCERPTS: For decades, publishing a paper in Nature was regarded as the ultimate academic achievement in China – a fast track to promotions, research grants, hospital appointments and elite national talent programmes.
Over the past two months, Chinese social media platforms have been flooded with accusations targeting papers published in Nature and its subsidiaries, including Nature Cancer, Nature Cell Biology and Nature Nanotechnology. Several of the accused authors are prominent professors, deans, “national talent” scholars and scientists with top state honours.
[...] As of May 17, Geng claimed to have another solid piece of evidence of fabrication in research papers published in Nature or its sister journals by four scholars holding prestigious state funding. For many Chinese researchers, the anger directed at Nature is not only about potential fraud, but also about what publication in the journal represents within China’s academic system.
A Nature paper can determine whether a scientist receives millions of yuan in funding, secures tenure, qualifies for national talent schemes or earns promotions at a leading hospital. Consequently, questionable papers are increasingly viewed not merely as cases of scientific misconduct, but as evidence of unfair resource allocation in an intensely competitive system.
[...] The reputational stakes are particularly high because China has become one of Nature’s largest markets. Nature and its parent company maintain extensive commercial ties across the country through academic conferences, publishing partnerships, training programmes, data services and collaborations with Chinese universities and research institutes.
A collapse in trust would therefore threaten not only prestige but also influence and business interests. [...] But the deeper impact may already be visible. For British publication Springer Nature, the greater danger may not be a handful of retractions, but the erosion of the authority and prestige it spent more than a century building... (MORE - details)